What Is New?
ATRIAL FIBRILLATION, ATRIAL FIBRILLATION (AF)

Women with atrial fibrillation (AF) enrolled in the CABANA (Catheter Ablation Versus Antiarrhythmic Drug Therapy for Atrial Fibrillation) trial had quality of life improvements with catheter ablation relative to drug therapy of equivalent magnitude to that seen in men.Women with AF had worse AF‐related quality of life than men both at baseline and at 12 months.Magnitude of quality of life benefit was larger for both men and women in subjects with lower (worse) baseline scores.